Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 3 Multiple Myeloma 3 Glioma 3 Glioblastoma 3 Endometrial Neoplasms 3 Diffuse Intrinsic Pontine Glioma 3 Triple Negative Breast Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Unspecified Adult Solid Tumor 1 Solid Tumors 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Obesity 1 Neuroendocrine Tumors 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Gliosarcoma 1 Fallopian Tube Neoplasms 1 Endometrial Cancer Recurrent 1 Disease 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinosarcoma 1 Breast Neoplasms, Male 1 Advanced Glioblastoma 1

Interventions

Magnetic Resonance Spectroscopy 16 Hydroxyurea 7 Everolimus 7 Bevacizumab 7 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 Proton Therapy 6 Specimen Handling 5 pembrolizumab 4 Surgical Procedures, Operative 4 Radiosurgery 4 Imatinib Mesylate 4 Cyclophosphamide 4 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4 aldesleukin 3 abemaciclib 3 Tranexamic Acid 3 Temozolomide 3 Sunitinib 3 Sodium Chloride 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Nivolumab 3 Ga(III)-DOTATOC 3 90Y-octreotide, DOTA-Tyr(3)- 3 vistusertib 2 trametinib 2 ribociclib 2 fludarabine 2 arginyllysine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Meningioma × TIC10 compound × Clear all

NCT06012929 2026-01-26

A Study of ONC201 for Refractory Meningioma

University of Nebraska

Phase 2 Withdrawn

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡